Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

disufenton sodium

A disulfonyl derivative of phenyl-tert-butyl nitrone (PBN), with potential anti-glioma activity. Although the exact mechanism(s) of action of OKN007 are still largely unknown, this agent appears to inhibit cancer cell proliferation and migration. This agent appears to inhibit the activity of sulfatase 2 (SULF2), a highly specific endoglucosamine-6-sulfatase that is overexpressed in the extracellular matrix of cancer cells and catalyzes the removal of sulfate from the 6-O-sulfate esters of heparin. In addition, OKN007 may induce changes in tumor metabolism and scavenge free radicals.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:2,4-disulfonyl PBN
2,4-disulfophenyl-tert-butylnitrone sodium
PBN derivative OKN-007
Code name:HPN-07
NXY-059
OKN-007
OKN007
Chemical structure:1,3-benzenedisulfonic Acid, 4-(((1,1-dimethylethyl)oxidoimino)methyl), disodium salt
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search